Clinical trials
Phase 2 Fibrosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 5 |
| Celgene | 2 |
| Axcella Health, Inc | 1 |
| Hoffmann-La Roche | 1 |
| Intercept Pharmaceuticals | 1 |
| Inventiva Pharma | 1 |
| Janssen Research & Development, LLC | 1 |
| Madrigal Pharmaceuticals, Inc. | 1 |
| Mannkind Corporation | 1 |
| Mediar Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 18 |
| Idiopathic Pulmonary Fibrosis | 5 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Lung Diseases | 3 |
| Lung Diseases, Interstitial | 3 |
| Pulmonary Fibrosis | 3 |
| Digestive System Diseases | 2 |
| Fatty Liver | 2 |
| Liver Cirrhosis | 2 |
| Pathologic Processes | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.